SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-024911
Filing Date
2014-04-25
Accepted
2014-04-25 16:06:14
Documents
2
Period of Report
2014-04-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v375915_8k.htm 8-K 23124
2 EXHIBIT 99.1 v375915_ex99-1.htm EX-99.1 7759
  Complete submission text file 0001144204-14-024911.txt   32673
Mailing Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158 646-666-3188
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 208133057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54365 | Film No.: 14785711
SIC: 2836 Biological Products, (No Diagnostic Substances)